ОБЗОР

Особенности течения сочетанной инфекции ВИЧ/SARS-CoV-2 в условиях пандемии

Информация об авторах

1 Республиканский центр по профилактике и борьбе со СПИД и инфекционными заболеваниями, Казань, Россия

2 Казанский (Приволжский) федеральный университет, Казань, Россия

3 Казанский государственный медицинский университет, Казань, Россия

Для корреспонденции: Альфия Фаридовна Олейник
ул. Гвардейская, д. 31/42-42, г. Казань, 420073; ur.xednay@kinieloayifla

Информация о статье

Вклад авторов: А. Ф. Олейник, Ч. Г. Реватхи — обзор литературы, подготовка рукописи; В. Х. Фазылов — подготовка рукописи.

Статья получена: 19.12.2020 Статья принята к печати: 26.01.2021 Опубликовано online: 08.02.2021
|
  1. Eis-Hübinger AM, Stifter G, Schneweis KE. Opportunistic infections with coronavirus-like particles in patients infected with the human immunodeficiency virus? Zentralbl Bakteriol. 1989 Sep; 271 (3): 351–5. DOI: 10.1016/s0934-8840(89)80034-9. PMID: 2553042; PMCID: PMC7135704.
  2. Chen XP, Cao Y. Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome. Clin Infect Dis. 2004 Apr 1; 38 (7): 1030–2. DOI: 10.1086/386340. Epub 2004 Mar 15. PMID: 15034838.
  3. Shalhoub S, AlZahrani A, Simhairi R, Mushtaq A. Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report. J Clin Virol. 2015 Jan; 62: 69–71. DOI: 10.1016/j.jcv.2014.11.030. Epub 2014 Nov 29. PMID: 25542475; PMCID: PMC7128447.
  4. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol. 2017 May 15; 198 (10): 4046–53. DOI: 10.4049/jimmunol.1601896. Epub 2017 Apr 3. PMID: 28373583; PMCID: PMC5450662.
  5. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020 Apr 8; 12 (7): 6049–57. DOI: 10.18632/ aging.103000. Epub 2020 Apr 8. PMID: 32267833; PMCID: PMC7185114.
  6. Promislow DEL. A Geroscience Perspective on COVID-19 Mortality. J Gerontol A BiolSci Med Sci. 2020 Sep 16; 75 (9): e30– e33. DOI: 10.1093/gerona/glaa094. PMID: 32300796; PMCID: PMC7184466.
  7. Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation, and Treatment of Coronavirus. [Updated 2020 Oct 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/.
  8. Gittelman RM, Lavezzo E, Snyder TM, Zahid HJ, Elyanow R, Dalai S, et al. Diagnosis and Tracking of Past SARS-CoV-2 Infection in a Large Study of Vo’, Italy Through T-Cell Receptor Sequencing. medRxiv [Preprint] 2020.11.09.20228023; 2020 [cited 2020 Nov 10] Available from: https://www.medrxiv.org/content/10.1101/20 20.11.09.20228023v1.
  9. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5; 383 (19): 1813–26. DOI: 10.1056/NEJMoa2007764. Epub 2020 Oct 8. PMID: 32445440; PMCID: PMC7262788.
  10. Балыкова Л. А., Грановская М. В., Заславская К. Я., Симакина Е. Н., Агафьина А. С., Иванова А. Ю. и др. Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир. Инфекционные болезни: новости, мнения, обучение. 2020. 3 (34): 16–29. DOI: 10.33029/23053496-2020-9-3-16-29.
  11. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15; 395 (10223): 507–13. DOI: 10.1016/ S0140-6736(20)30211-7. Epub 2020 Jan 30. PMID: 32007143; PMCID: PMC7135076.
  12. World Health Organization (2020 Sep 2) [cited 2020 Nov 19] Available from: https://www.who.int/news-room/feature-stories/ detail/who-updates-clinical-care-guidance-with-corticosteroidrecommendations.
  13. Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: A global perspective. J Med Virol. 2020 Jul 21. DOI: 10.1002/jmv.26321. Epub ahead of print. PMID: 32692406; PMCID: PMC7404432.
  14. Zhu F, Cao Y, Xu S, Zhou M. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. J Med Virol. 2020 Jun; 92 (6): 529–30. DOI: 10.1002/jmv.25732. Epub 2020 Mar 11. PMID: 32160316; PMCID: PMC7228399.
  15. Huang J, Xie N, Hu X, Yan H, Ding J, Liu P, et al. Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study. Clin Infect Dis. 2020 Aug 17: ciaa1186. DOI: 10.1093/cid/ciaa1186. Epub ahead of print. PMID: 32803216; PMCID: PMC7454403.
  16. European AIDS Clinical Society. EACS-BHIVA, G. B statement (1 April 2020) [cited 2020 Nov 19]. Available from: https://www. eacsociety.org/home/eacs-bhiva-statement-1-april.html.
  17. Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, et al. Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019. Clin Infect Dis. 2020 Nov 19; 71 (16): 2294–7. DOI: 10.1093/cid/ciaa635. PMID: 32472138; PMCID: PMC7314170.
  18. Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020 May; 7 (5): e314–e316. DOI: 10.1016/S23523018(20)30111-9. Epub 2020 Apr 15. PMID: 32304642; PMCID: PMC7159872.
  19. Stoeckle K, Johnston CD, Jannat-Khah DP, Williams SC, Ellman TM, Vogler MA, et al. COVID-19 in Hospitalized Adults With HIV. Open Forum Infect Dis. 2020 Aug 1; 7 (8): ofaa327. DOI: 10.1093/ ofid/ofaa327. PMID: 32864388; PMCID: PMC7445584.
  20. Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, et al. Outcomes Among HIV-Positive Patients Hospitalized With COVID-19. J Acquir Immune DeficSyndr. 2020 Sep 1; 85 (1): 6–10. DOI: 10.1097/QAI.0000000000002423. PMID: 32568770; PMCID: PMC7446982.
  21. Davies MA. HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. medRxiv [Preprint]. 2020 Jul 3: 2020.07.02.20145185. DOI: 10.1101/2020.07.02.20145185. PMID: 32637972; PMCID: PMC7340198.
  22. Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020 Aug; 7 (8): e554–e564. DOI: 10.1016/S2352-3018(20)30164-8. Epub 2020 May 28. PMID: 32473657; PMCID: PMC7255735.
  23. Childs K, Post FA, Norcross C, Ottaway Z, Hamlyn E, Quinn K, et al. Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series. Clin Infect Dis. 2020 Nov 5; 71 (8): 2021–2. DOI: 10.1093/cid/ciaa657. PMID: 32459833; PMCID: PMC7314116.
  24. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020 Nov; 92 (11): 2288–90. DOI: 10.1002/jmv.25955. Epub 2020 Jun 3. PMID: 32347975
  25. Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS. 2020 Oct 1; 34 (12): 1775–80. DOI: 10.1097/QAD.0000000000002643. PMID: 32773471; PMCID: PMC7493771.
  26. Gudipati S, Brar I, Murray S, McKinnon JE, Yared N, Markowitz N. Descriptive Analysis of Patients Living With HIV Affected by COVID-19. J Acquir Immune DeficSyndr. 2020 Oct 1; 85 (2): 123– 6. DOI: 10.1097/QAI.0000000000002450. PMID: 32675771; PMCID: PMC7446990.
  27. Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, Okuhama A, Akiyama Y, et al. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan. J Med Virol. 2020 Jun 3: 10.1002/ jmv.26102. DOI: 10.1002/jmv.26102. Epub ahead of print. PMID: 32492188; PMCID: PMC7300885.
  28. Nagarakanti SR, Okoh AK, Grinberg S, Bishburg E. Clinical outcomes of patients with COVID-19 and HIV coinfection. J Med Virol. 2020 Sep 19. DOI: 10.1002/jmv.26533. Epub ahead of print. PMID: 32949148; PMCID: PMC7537324.
  29. Mondi A, Cimini E, Colavita F, Cicalini S, Pinnetti C, Matusali G, et al. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2020 Sep 25. DOI: 10.1002/jmv.26556. Epub ahead of print. PMID: 32975842; PMCID: PMC7537181.
  30. Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, et al. Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19. Clin Infect Dis. 2020 Nov 19; 71 (16): 2276–78. DOI: 10.1093/cid/ciaa579. PMID: 32407467; PMCID: PMC7239244.
  31. Zhao J, Liao X, Wang H, Wei L, Xing M, Liu L, et al. Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus. Clin Infect Dis. 2020 Nov 19; 71 (16): 2233–35. DOI: 10.1093/cid/ciaa408. PMID: 32270178; PMCID: PMC7184426.
  32. Hu Y, Ma J, Huang H, Vermund SH. Coinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series. J Acquir Immune Defic Syndr. 2020 Sep 1; 85 (1): 1–5. DOI: 10.1097/QAI.0000000000002424. PMID: 32568771; PMCID: PMC7446977.
  33. Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city. J Med Virol. 2020 Nov; 92 (11): 2387–9. DOI: 10.1002/jmv.26077. Epub 2020 Jun 9. PMID: 32462663; PMCID: PMC7283854.
  34. Mascolo S, Romanelli A, Carleo MA, Esposito V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. J Med Virol. 2020 Oct; 92 (10): 1777–8. DOI: 10.1002/jmv.25881. Epub 2020 Jul 11. PMID: 32293709; PMCID: PMC7262314.
  35. Yang R, Gui X, Zhang Y, Xiong Y, Gao S, Ke H. Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China. Expert Rev Respir Med. 2020 Oct 27: 1–7. DOI: 10.1080/17476348.2021.1836965. Epub ahead of print. PMID: 33074039; PMCID: PMC7605649.
  36. Ho HE, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, et al. Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV. J Infect Dis. 2020 Jun 30: jiaa380. DOI: 10.1093/ infdis/jiaa380. Epub ahead of print. PMID: 32601704; PMCID: PMC7337732.
  37. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010 Jun 15; 201 (12): 1788–95. DOI: 10.1086/652749. PMID: 20446848; PMCID: PMC2872049.
  38. Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M, et al. ImmuneInflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020 Jun 9; 7: 301. DOI: 10.3389/fmed.2020.00301. PMID: 32582743; PMCID: PMC7295898.
  39. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24; 12 (1): 8. DOI: 10.1038/s41368-020-0074-x. PMID: 32094336; PMCID: PMC7039956.
  40. Biegler B, Kasinrerk W. Reduction of CD147 surface expression on primary T cells leads to enhanced cell proliferation. Asian Pac J Allergy Immunol. 2012 Dec; 30 (4): 259–67. PMID: 23393905.
  41. Chan KS, Lai ST, Chu CM, Tsui E, Tam CY, Wong MM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003 Dec; 9 (6): 399–406. PMID: 14660806.
  42. Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci. 2020 Jul 15; 253: 117592. DOI: 10.1016/j.lfs.2020.117592. Epub 2020 Mar 25. Erratum in: Life Sci. 2020 Oct 1; 258: 118350. PMID: 32222463; PMCID: PMC7102646.
  43. Liu J, Zeng W, Cao Y, Cui Y, Li Y, Yao S, et al. Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study. Int J Infect Dis. 2020 Nov; 100: 141–8. DOI: 10.1016/j. ijid.2020.08.045. Epub 2020 Aug 20. PMID: 32829051; PMCID: PMC7439831.
  44. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7; 382 (19): 1787–99. DOI: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. PMID: 32187464; PMCID: PMC7121492.
  45. Ayerdi O, Puerta T, Clavo P, Vera M, Ballesteros J, Fuentes ME, et al. Preventive efficacy of Tenofovir/Emtricitabine against severe acute respiratory syndrome Coronavirus 2 among pre-exposure prophylaxis users. Open Forum Infect Dis. 2020 Sep 25; 7 (11): ofaa455. DOI: 10.1093/ofid/ofaa455. PMID: 33200081; PMCID: PMC7543639.
  46. Musarrat F, Chouljenko V, Dahal A, Nabi R, Chouljenko T, Jois SD, et al. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections. J Med Virol. 2020 Oct; 92 (10): 2087–95.